Protect the people we love and care for
globally and in our local communities
Firstline is a health technology platform that makes clinical guidance on infectious diseases easily accessible at the point of care. We empower every prescriber to make the best treatment decisions based on expert knowledge.
With you, we win! Join us to preserve the efficacy of vital antibiotics and protect humans, animals, and our environment.
Together, our prescribing actions can have profound impact, delivering better patient care, reducing healthcare costs, and curbing the spread of drug-resistant infections.
For global health organizations
Global organizations partner with Firstline to transform world-leading ID expertise into effective stewardship actions that protect modern medicine.
Firstline is proven to simplify the localization of global guidance. Expand usage across prescribing communities and scale a unified AMR movement like no other.
For state authorities, health systems & hospitals
State authorities, health systems, and hospitals, team with Firstline to deliver your tailor-made ID guidance to every provider at the point of care. Empower evidence-based treatment decisions that improve patient outcomes and drive savings of over $550/bed/year.
Joey Kohn, PharmD, BCPS, Prisma Health-Midlands
Read More -->
Antibiotic stewardship (AS) interventions in paediatrics are still not standardized regarding methodology, metrics, and outcomes. We report the results of an AS intervention in the paediatric area based on education and guideline provision via an electronic App.
Last year, Children’s Hospital Colorado’s Antimicrobial Stewardship Program was nationally recognized for playing an important role in optimizing the use of antibiotics for better pediatric patient and hospital outcomes. Now, the Children’s Colorado Antimicrobial Stewardship team, along with teams from Denver Health and the Colorado Department of Public Health and Environment (CDPHE), have partnered with Firstline, a health technology company, to design a mobile version of their infectious disease guidance and deliver it to all healthcare providers in Colorado.
Canada could transform from global laggard to a global leader in the fight against antimicrobial resistance.
Canada’s Auditor-General released a report on October 19th concluding that the federal government has not done enough to protect Canadians from the spread of antimicrobial resistant pathogens, commonly known as “superbugs.” This is roughly the same conclusion the Auditor-General reached nearly a decade ago, and few experts will be surprised at the findings of the report despite the urgency of the growing threat.
